Current Affairs & MCQs
Latest Questions, Daily Updates & More

MCQs 2026

191.
Which of the following is a key characteristic of hypersonic missiles that makes them difficult to intercept?
A Low altitude flight path
B Stealth technology
C Maneuverability at high speeds
D Use of conventional explosives
192.
The development of Agni-VI showcases India's progress in which sector?
A Information Technology
B Indigenous Defense Manufacturing
C Biotechnology
D Automotive Industry
193.
The successful test of Agni-VI enhances India's capability in which area?
A Space exploration
B Cyber warfare
C Strategic deterrence
D Renewable energy
194.
What makes hypersonic missiles a significant challenge to existing defense systems?
A Their slow speed and predictable trajectory
B Their extreme speed and maneuverability
C Their reliance on satellite guidance
D Their limited range
195.
What is the minimum speed threshold for a missile to be classified as hypersonic?
A Mach 1
B Mach 3
C Mach 5
D Mach 10
196.
What does 'preclinical trials' typically involve in drug development?
A Testing on human patients in a hospital setting
B Testing on animals and in laboratory settings before human trials
C Large-scale marketing and distribution
D Regulatory approval from government bodies
197.
The success of 'PharmAI' in Alzheimer's research highlights the growing role of AI in which sector?
A Manufacturing
B Agriculture
C Education
D Healthcare and Pharmaceutical Research
198.
How did 'PharmAI' contribute to accelerating the drug discovery process?
A By conducting extensive clinical trials
B By predicting molecular interactions and identifying drug candidates more efficiently
C By manufacturing drugs at a lower cost
D By developing new surgical techniques
199.
Which specific pathologies of Alzheimer's disease did the AI platform 'PharmAI' target?
A Neurotransmitter imbalances
B Inflammation of brain tissue
C Amyloid-beta plaques and tau tangles
D Reduced blood flow to the brain
200.
What is a primary challenge in traditional drug discovery that AI aims to address?
A Lack of scientific interest
B High cost, long timelines, and low success rates
C Limited availability of research funding
D Over-reliance on traditional medicine